具有射频响应的黑纳米凝与西斯交叉连接,用于多模式瘤疗法的精确协同作用
Can Hong1, Yiming Liu2, Dingwen Shi1
1National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, 430074 Wuhan, PR China.
概括
射频响应纳米粒子 (RFNP) 通过将射频剥离与化疗相结合来增强癌症治疗. 这种新的黑纳米凝在射频辐射下触发药物释放和免疫反应,以改善瘤抑制.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 射频响应纳米粒子 (RFNP) 显示出在癌症治疗中增强射频剥离 (RFA) 的前景.
- 在开发具有临床生物安全性和协同抗瘤作用的生物相容性的无机RFNP方面仍然存在挑战.
研究的目的:
- 制造一种新型的RF响应黑 (BP) 纳米凝 (BP-Pt@PNA) 用于协同治疗癌症.
- 评估BP-Pt@PNA与RFA结合的生物安全性,药物释放和抗瘤疗效.
主要方法:
- 制造BP-Pt@PNA通过与BP和温度敏感聚合物PNA交叉连接西斯普拉丁.
- 评估射频加热效应,射频诱导的西斯释放,以及在4T1细胞上的体外细胞毒性.
- 对协同抗瘤效应的评估,包括射频刺激的免疫反应,瘤生长抑制和体内转移抑制.
主要成果:
- 在射频辐射后,BP-Pt@PNA显示出强大的射频加热和脉动性西斯普拉丁释放.
- 血压和西斯普拉丁的协同作用诱导了RF刺激的全身免疫反应,增强了瘤抑制和减少转移.
- BP-Pt@PNA在瘤中实现了持续的药物保留和瘤食动脉的栓塞.
结论:
- BP-Pt@PNA是一种有前途的RFNP,可以精确地将RFA与其他抗瘤方式结合起来.
- 纳米凝表现出有利的生物安全性,生物降解性和高药物载荷能力.
- 这种方法为晚期癌症治疗提供了临床适用的策略.
更多相关视频
07:47Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
Published on: December 13, 2015
9.0K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.5K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K